Tryptophan catabolites, inflammation, and insulin resistance as determinants of chronic fatigue syndrome and affective symptoms in long COVID
- PMID: 37333619
- PMCID: PMC10272345
- DOI: 10.3389/fnmol.2023.1194769
Tryptophan catabolites, inflammation, and insulin resistance as determinants of chronic fatigue syndrome and affective symptoms in long COVID
Abstract
Critical COVID-19 disease is accompanied by depletion of plasma tryptophan (TRY) and increases in indoleamine-dioxygenase (IDO)-stimulated production of neuroactive tryptophan catabolites (TRYCATs), including kynurenine (KYN). The TRYCAT pathway has not been studied extensively in association with the physiosomatic and affective symptoms of Long COVID. In the present study, we measured serum TRY, TRYCATs, insulin resistance (using the Homeostatic Model Assessment Index 2-insulin resistance, HOMA2-IR), C-reactive protein (CRP), physiosomatic, depression, and anxiety symptoms in 90 Long COVID patients, 3-10 months after remission of acute infection. We were able to construct an endophenotypic class of severe Long COVID (22% of the patients) with very low TRY and oxygen saturation (SpO2, during acute infection), increased kynurenine, KYN/TRY ratio, CRP, and very high ratings on all symptom domains. One factor could be extracted from physiosomatic symptoms (including chronic fatigue-fibromyalgia), depression, and anxiety symptoms, indicating that all domains are manifestations of the common physio-affective phenome. Three Long COVID biomarkers (CRP, KYN/TRY, and IR) explained around 40% of the variance in the physio-affective phenome. The latter and the KYN/TRY ratio were significantly predicted by peak body temperature (PBT) and lowered SpO2 during acute infection. One validated latent vector could be extracted from the three symptom domains and a composite based on CRP, KYN/TRY, and IR (Long COVID), and PBT and SpO2 (acute COVID-19). In conclusion, the physio-affective phenome of Long COVID is a manifestation of inflammatory responses during acute and Long COVID, and lowered plasma tryptophan and increased kynurenine may contribute to these effects.
Keywords: affective symptoms; chronic fatigue syndrome; indoleamine-2,3-dioxygenase; inflammation; neuro-immune; neurotoxicity.
Copyright © 2023 Al-Hakeim, Khairi Abed, Rouf Moustafa, Almulla and Maes.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures




Similar articles
-
Lowered Quality of Life in Long COVID Is Predicted by Affective Symptoms, Chronic Fatigue Syndrome, Inflammation and Neuroimmunotoxic Pathways.Int J Environ Res Public Health. 2022 Aug 19;19(16):10362. doi: 10.3390/ijerph191610362. Int J Environ Res Public Health. 2022. PMID: 36011997 Free PMC article.
-
Lowered oxygen saturation and increased body temperature in acute COVID-19 largely predict chronic fatigue syndrome and affective symptoms due to Long COVID: A precision nomothetic approach.Acta Neuropsychiatr. 2023 Apr;35(2):76-87. doi: 10.1017/neu.2022.21. Epub 2022 Sep 22. Acta Neuropsychiatr. 2023. PMID: 36134517
-
Chronic Fatigue, Depression and Anxiety Symptoms in Long COVID Are Strongly Predicted by Neuroimmune and Neuro-Oxidative Pathways Which Are Caused by the Inflammation during Acute Infection.J Clin Med. 2023 Jan 8;12(2):511. doi: 10.3390/jcm12020511. J Clin Med. 2023. PMID: 36675440 Free PMC article.
-
The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression.Prog Neuropsychopharmacol Biol Psychiatry. 2011 Apr 29;35(3):702-21. doi: 10.1016/j.pnpbp.2010.12.017. Epub 2010 Dec 23. Prog Neuropsychopharmacol Biol Psychiatry. 2011. PMID: 21185346 Review.
-
IDO chronic immune activation and tryptophan metabolic pathway: A potential pathophysiological link between depression and obesity.Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jan 3;80(Pt C):234-249. doi: 10.1016/j.pnpbp.2017.04.035. Epub 2017 Jun 12. Prog Neuropsychopharmacol Biol Psychiatry. 2018. PMID: 28595944 Review.
Cited by
-
Core features and inherent diversity of post-acute infection syndromes.Front Immunol. 2025 Jun 3;16:1509131. doi: 10.3389/fimmu.2025.1509131. eCollection 2025. Front Immunol. 2025. PMID: 40529374 Free PMC article. Review.
-
Increased insulin resistance is associated with depressive symptoms due to Long COVID.Braz J Psychiatry. 2023 May 1;45(4):380-1. doi: 10.47626/1516-4446-2023-0048. Online ahead of print. Braz J Psychiatry. 2023. PMID: 37127292 Free PMC article. No abstract available.
-
Understanding the kynurenine pathway: A narrative review on its impact across chronic pain conditions.Mol Pain. 2024 Jan-Dec;20:17448069241275097. doi: 10.1177/17448069241275097. Mol Pain. 2024. PMID: 39093627 Free PMC article. Review.
-
Favorable responses to upadacitinib, a JAK1 inhibitor, in long COVID patients with predominant neuropsychiatric symptoms: case reports in 2 autistic patients and one typically developing patient.BMC Neurol. 2025 Aug 20;25(1):342. doi: 10.1186/s12883-025-04341-y. BMC Neurol. 2025. PMID: 40830439 Free PMC article.
-
Significance of nitrosative stress and glycoxidation products in the diagnosis of COVID-19.Sci Rep. 2024 Apr 22;14(1):9198. doi: 10.1038/s41598-024-59876-w. Sci Rep. 2024. PMID: 38649417 Free PMC article.
References
-
- Al-Jassas H. K., Al-Hakeim H. K., Maes M. (2022). Intersections between pneumonia, lowered oxygen saturation percentage and immune activation mediate depression, anxiety, and chronic fatigue syndrome-like symptoms due to COVID-19: a nomothetic network approach. J. Affect. Disord. 297, 233–245. doi: 10.1016/j.jad.2021.10.039 - DOI - PMC - PubMed
-
- Al-Hadrawi D. S., Al-Rubaye H. T., Almulla A. F., Al-Hakeim H. K., Maes M. (2022). Lowered oxygen saturation and increased body temperature in acute COVID-19 largely predict chronic fatigue syndrome and affective symptoms due to LONG COVID: a precision nomothetic approach. Acta Neuropsychiat. 297, 1–12. doi: 10.1017/neu.2022.21 - DOI - PubMed
-
- Al-Hakeim H. K., Al-Rubaye H. T., Al-Hadrawi D. S., Almulla A. F., Maes M. (2023a). Long-COVID post-viral chronic fatigue and affective symptoms are associated with oxidative damage, lowered antioxidant defenses and inflammation: a proof of concept and mechanism study. Mol. Psychiatry 28, 564–578. doi: 10.1038/s41380-022-01836-9, PMID: - DOI - PMC - PubMed
-
- Al-Hakeim H. K., Al-Rubaye H. T., Almulla A. F., Al-Hadrawi D. S., Maes M. (2023b). Chronic fatigue, depression and anxiety symptoms in long COVID are strongly predicted by Neuroimmune and Neuro-oxidative pathways which are caused by the inflammation during acute infection. J. Clin. Med. 12:511. doi: 10.3390/jcm12020511, PMID: - DOI - PMC - PubMed
-
- Al-Hakeim H.K., Al-Rubaye H., Jubran A., Almulla A., Moustafa S., Maes M. (2022). Increased insulin resistance due to long COVID is associated with depressive symptoms and partly predicted by the inflammatory response during acute infection. Braz. J. Psychiatry doi: 10.47626/1516-4446-2022-3002 [Epub ahead of print]. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous